Neoplasms of the brain and spinal cord are tumors that originate in the brain or spinal cord. They may be benign or malignant and may grow at different rates, which can have a significant impact on a patient's prognosis. The most common types of brain and spinal cord tumors are meningiomas, astrocytomas, and schwannomas. Meningiomas are tumors that originate in the membranes that surround and protect the brain and spinal cord. They are typically benign, slow-growing tumors and can be treated with excision, radiation, or both depending on the severity of the tumor. Astrocytomas originate from glial cells, which are non-neuron al cells that play a role in maintaining and protecting the nerve cells of the brain. These tumors can be benign or malignant and may or may not be treated with radiation, chemotherapy and/or surgery depending on the severity. Schwannomas are tumors that originate from Schwann cells, which are cells that line the spine and are responsible for producing the protective myelin sheath around nerve cells. These tumors are typically benign and are always treated with surgical excision. In addition to these common brain and spinal cord tumors, patients can also develop rare, more aggressive forms of brain tumors. These include glioblastomas, oligoastrocytomas, and choroid plexus tumors. Glioblastomas are unpredictable and aggressive tumors that originate from glial cells and are treated with a combination of surgery, radiation, and chemotherapy. Oligoastrocytomas are slow-growing tumors that often originate from the cerebellum and are treated with a combination of surgery and radiation therapy. Choroid plexus tumors usually originate in the brain’s ventricular system and can be either benign or malignant. They can be difficult to detect and are usually treated with surgery and radiation.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States